Trulieve CEO: Scientific Cannabis Transition | Furious Money | CNBC

Trulieve CEO: Scientific Cannabis Transition | Furious Money | CNBC

It’s a medical marijuana company helping over 80,000 sufferers and it is possible you’ll seemingly seemingly maintain by no system heard of it. Jim Cramer looks into Trulieve and what…

Read more »
Tilray CEO: Alternatives in scientific cannabis are colossal

Tilray CEO: Alternatives in scientific cannabis are colossal

Tilray’s inventory is up as of late, nonetheless peaceful down 80 p.c from a February high. CNBC’s Frank Holland experiences on his conversation with Tilray CEO Irwin Simon about the…

Read more »